Please use this identifier to cite or link to this item: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3848
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNg, Felix C-
dc.contributor.authorChurilov, Leonid-
dc.contributor.authorYassi, Nawaf-
dc.contributor.authorKleinig, Timothy J-
dc.contributor.authorThijs, Vincent-
dc.contributor.authorWu, Teddy Y-
dc.contributor.authorShah, Darshan-
dc.contributor.authorDewey, Helen M-
dc.contributor.authorSharma, Gagan-
dc.contributor.authorDesmond, Patricia M-
dc.contributor.authorYan, Bernard-
dc.contributor.authorParsons, Mark W-
dc.contributor.authorDonnan, Geoffrey A-
dc.contributor.authorDavis, Stephen M-
dc.contributor.authorMitchell, Peter J-
dc.contributor.authorCampbell, Bruce C. V.-
dc.date.accessioned2023-04-24T02:44:20Z-
dc.date.available2023-04-24T02:44:20Z-
dc.date.issued2021-
dc.identifier.urihttps://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3848-
dc.description.abstractThe relationship between reperfusion and edema is unclear, with experimental and clinical data yielding conflicting results. We investigated whether the extent of salvageable and irreversibly-injured tissue at baseline influenced the effect of therapeutic reperfusion on cerebral edema. In a pooled analysis of 415 patients with anterior circulation large vessel occlusion from the Tenecteplase-versus-Alteplase-before-Endovascular-Therapy-for-Ischemic-Stroke (EXTEND-IA TNK) part 1 and 2 trials, associations between core and mismatch volume on pre-treatment CT-Perfusion with cerebral edema at 24-hours, and their interactions with reperfusion were tested. Core volume was associated with increased edema (p < 0.001) with no significant interaction with reperfusion (p = 0.82). In comparison, a significant interaction between reperfusion and mismatch volume (p = 0.03) was observed: Mismatch volume was associated with increased edema in the absence of reperfusion (p = 0.009) but not with reperfusion (p = 0.27). When mismatch volume was dichotomized at the median (102 ml), reperfusion was associated with reduced edema in patients with large mismatch volume (p < 0.001) but not with smaller mismatch volume (p = 0.35). The effect of reperfusion on edema may be variable and dependent on the physiological state of the cerebral tissue. In patients with small to moderate ischemic core volume, the benefit of reperfusion in reducing edema is related to penumbral salvage.-
dc.relation.isversionof20210517-
dc.subjectIntravenous-
dc.subjectAged-
dc.subjectBrain Edema-
dc.subjectEndovascular Procedures-
dc.subjectFemale-
dc.subjectFibrinolytic Agents-
dc.subjectFollow-Up Studies-
dc.subjectHumans-
dc.subjectIschemic Stroke-
dc.subjectMale-
dc.subjectMiddle Aged-
dc.subjectNeuroimaging-
dc.subjectPerfusion Imaging-
dc.subjectProspective Studies-
dc.subjectReperfusion-
dc.subjectTenecteplase-
dc.subjectTissue Plasminogen Activator-
dc.subjectTomography-
dc.subjectTreatment Outcome-
dc.subjectAcute Stroke-
dc.subjectBrain Edema-
dc.subjectBrain Imaging-
dc.subjectBrain Ischemia-
dc.subjectReperfusion-
dc.titleAssociation between pre-treatment perfusion profile and cerebral edema after reperfusion therapies in ischemic stroke-
dc.typeJournal Article-
dc.identifier.journaltitleJournal of Cerebral Blood Flow and Metabolism-
dc.accession.number33993795-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pubmed/33993795-
dc.description.affiliationDepartment of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.-
dc.description.affiliationDepartment of Neurology, Austin Hospital, Austin Health, Heidelberg, Australia.-
dc.description.affiliationThe Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.-
dc.description.affiliationDepartment of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.-
dc.description.affiliationPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.-
dc.description.affiliationDepartment of Neurology, Royal Adelaide Hospital, Adelaide, Australia.-
dc.description.affiliationDepartment of Neurology, Christchurch Hospital, Christchurch, New Zealand.-
dc.description.affiliationDepartment of Neurology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.-
dc.description.affiliationEastern Health and Eastern Health Clinical School, Department of Neurosciences, Monash University, Clayton, Australia.-
dc.description.affiliationDepartment of Radiology, the Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.-
dc.format.startpage2887-2896-
dc.source.volume41-
local.issue.number11-
dc.identifier.noteseng-
dc.identifier.notesClinical Trial, Phase I-
dc.identifier.notesClinical Trial, Phase II-
dc.identifier.notesComparative Study-
dc.identifier.notesMulticenter Study-
dc.identifier.notesRandomized Controlled Trial-
dc.identifier.notes2021/05/18-
dc.identifier.importdoi10.1177/0271678X211017696-
dc.identifier.date2021-
Appears in Collections:SWH Data Contributions



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing